Indaptus Therapeutics, Inc. (INDP) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.51M | +47.0% |
| 2024 | $5.79M | -56.7% |
| 2023 | $13.36M | +38.8% |
| 2022 | $9.63M | -75.4% |
| 2021 | $39.13M | +2289.8% |
| 2020 | $1.64M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $8.51M | +47.0% |
| 2024 | $5.79M | -56.7% |
| 2023 | $13.36M | +38.8% |
| 2022 | $9.63M | -75.4% |
| 2021 | $39.13M | +2289.8% |
| 2020 | $1.64M | — |